Iovance Biotherapeutics Inc. (NASDAQ:IOVA) is one of the most promising penny stocks under $5 to buy. On February 24, Iovance Biotherapeutics reported earnings for Q4 and the full year 2025, highlighted by a 61% year-over-year increase in total annual revenue to $264 million. Q4 alone generated $87 million in product revenue, representing 30% growth over the previous quarter. This growth was largely driven by the success of Amtagvi, which saw a 112% increase in year-over-year revenue, alongside improved op ...